Browse the full directors' dealings record of Algernon Health Inc., a listed equity based in Canada. Shares trade on CA CA, under the authority of SEDI. The latest transaction was disclosed on 18 November 2025 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Moreau, Christopher. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Algernon Health Inc. is a company focused on developing innovative treatments for serious diseases. It is listed on the XTSE market.